This Chinese Biotech Is Developing A Immune-privileged Cell And Organ Platform

This Chinese Biotech Is Developing A Immune-privileged Cell And Organ Platform

Hangzhou Qihan Biotechnology Co., Ltd. is innovating in transplantable cells, tissues, and organs to solve the massive organ shortage crisis. The company targets the scientific challenge of specific cell therapy by developing a multiplexable high-throughout gene-editing platform. The platform’s key feature is to reduce the immunogenicity of human stem cells, thus limiting their ability to … Read more

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

Taimei Technology of Shanghai completed a $176 million financing to support its AI cloud-based suite of programs for clinical trials and drug safety. The company’s SAAS platform enables clinical research collaboration between sponsors, sites, CROs, patients, regulatory agencies and third-party providers. Its latest funding was co-led by Tencent Holdings, GL Ventures (a Hillhouse subsidiary), and YF Capital, … Read more

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

Immvira Group Company announced this week the completion of series B financing for $58 million. The biotechnology startup focuses on the development of new generation oncolytic viruses as potential cancer therapeutics. Immvirva attracted a number of biotech investors. This round of financing was led by Huagai Capital, with participation by Apricot Capital, Cowin Capital. The funds … Read more

Verisim Life’s In Silico AI Aims To Replace Animal Testing To Improve Drug Development

Verisim Life’s In Silico AI Aims To Replace Animal Testing To Improve Drug Development

VeriSIM Life (VSL), a San Francisco-based biotechnology startup, builds artificial intelligence (AI)-enabled biosimulation models to accelerate drug development. The company’s BIOiSIM tool is an in-house technology that enables simulation and prediction of drug disposition in human and animal bodies. The company’s goal is lofty. VSL is attempting to model whole human biology to solve, in … Read more

This Startup Is Innovating In Real World Data And AI

This Startup Is Innovating In Real World Data And AI

Concerto HealthAI, a SymphonyAI Group portfolio company, is innovating in real world data (RWD) and AI solutions for precision oncology. The company’s mission is to bring together unique data assets, AI-based technologies, and top outcomes research and data science talent. Concerto HealthAI’s focus is on revolutionizing clinical and outcomes research to accelerate the insights benefiting … Read more

This Startup Is Innovating In Enzymatic DNA Synthesis

This Startup Is Innovating In Enzymatic DNA Synthesis

Ansa Biotechnologies, Inc, a Berkeley, CA-based startup, is developing a technique to control additions of a polymerase that use TdT for de novo DNA synthesis. The ability to synthesize “gene-length” DNA molecules (>500 bases) is invaluable for biological and biomedical research and is a key enabling technology for the rapidly growing field of synthetic biology. … Read more